NCT00456625 Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine. Status COMPLETED Phase PHASE4
NCT00455572 Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE1
NCT00454987 Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine Status COMPLETED Phase PHASE4
NCT00454909 Immunogenicity and Safety of Meningococcal Vaccine GSK134612 vs. Menactra® in Healthy Adolescent/Adults Aged 10-25 Years. Status COMPLETED Phase PHASE2
NCT00454675 Pulmonary Function Changes in 10 Pack Year Smokers With Chronic Bronchitis Status COMPLETED Phase N/A
NCT00453986 Lot Consistency, Immuno, Safety of Meningococcal Vaccine GSK134612 Given With Fluarix™ to 18-55 Year-Old Adults Status COMPLETED Phase PHASE3
NCT00453791 The Safety and Tolerability of GW805858 in Healthy Volunteers and Mild Asthmatics Status TERMINATED Phase PHASE1
NCT00453778 A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients Status COMPLETED Phase PHASE4
NCT00453687 A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK233705 In Healthy Volunteers. Status COMPLETED Phase PHASE1
NCT00453479 A Dose Ascending, Study To Examine The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of GSK233705B. Status COMPLETED Phase PHASE2
NCT00453440 Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 Status COMPLETED Phase N/A
NCT00452699 A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma Status COMPLETED Phase PHASE4
NCT00452686 Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine Status COMPLETED Phase PHASE3
NCT00452348 A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With Asthma Status COMPLETED Phase PHASE4
NCT00450892 Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00450580 HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults Status COMPLETED Phase PHASE3
NCT00450203 Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer Status UNKNOWN Phase PHASE2/PHASE3